Latest News and Press Releases
Want to stay updated on the latest news?
-
HAMBURG, Germany, Sept. 15, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and the Jain Foundation Inc. today announced that they have further extended and expanded...
-
HAMBURG, Germany, Sept. 11, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that CHDI Foundation, Inc. ("CHDI") has extended and restated its...
-
HAMBURG, Germany, Sept. 8, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVC) (ISIN: DE 000 566480 9) (WKN 566480) was informed that US company Hyperion Therapeutics, Inc. ("Hyperion") is...
-
HAMBURG, Germany, and BRANFORD, Conn., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced the start of a multi-year compound management agreement...
-
IMPROVED OPERATIONAL PERFORMANCE AND INCREASED REVENUES GOOD PIPELINE PROGRESS ACQUISITION EXPANDS CAPABILITIES AND EXPERTISE IN INFECTIOUS DISEASES HAMBURG, Germany, Aug. 12, 2014...
-
HAMBURG, Germany, July 30, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced the successful achievement of the first milestones in its TargetAD...
-
HAMBURG, Germany, July 8, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today an exclusive strategic collaboration with the Fraunhofer Institute for...
-
HAMBURG, Germany, June 19, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone...
-
Actions of Management Board and Supervisory Board approved New Supervisory Board elected: Prof. Dr Wolfgang Plischke new Chairman of the Supervisory Board Authorised Capital 2014...
-
ADDS KEY KNOW-HOW AND INFECTIOUS DISEASE THERAPEUTIC AREA CAPABILITIES STRENGTHENS EVT EXECUTE AND EVT INNOVATE BUSINESS BY ESTABLISHING AN ANTI-INFECTIVE PLATFORM INITIAL...